Member exclusive

Medicare Administrative Contractors Drop New Proposed Botulinum Toxin Policies

Apr 01, 2026

Four MACs made unexpected revisions to the policies that were finalized in January 2026, adding Xeomin dosage guidance for blepharospasm.

Member exclusive

Log in to keep reading.

Join AAO to get unlimited access to content. See member benefits or join today.